{"schema_version":"secwatch.filing_event.v1","accession":"0001493152-21-016427","form_type":"8-K","ticker":"NEPH","cik":"0001196298","company_name":"NEPHROS INC","filed_at":"2021-07-08T23:59:59+00:00","discovered_at":"2026-05-14T18:04:17.398287+00:00","generated_at":"2026-06-30T06:32:32.174632+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"positive","materiality_score":0.7,"calibrated_materiality_score":0.7,"confidence":"high","headline":"Nephros reports preliminary Q2 2021 revenue $2.2M (+40% YoY); submits HDF product for FDA 510(k) clearance","bullets":["Preliminary Q2 2021 net revenue ~$2.2M, >40% year-over-year increase.","Six-month revenue >$5M, up 20% vs same periods in 2020 and 2019.","Subsidiary SRP submitted HDF Assist Module for FDA 510(k) clearance; commercial launch planned at limited dialysis clinics.","Pathogen Detection Systems segment generated >$50k in Q2 from on-site testing services.","Consolidated cash at quarter end ~$8.3M."],"urls":{"canonical":"https://secwatch.observer/filing/0001493152-21-016427","json":"https://secwatch.observer/filing/0001493152-21-016427.json","markdown":"https://secwatch.observer/filing/0001493152-21-016427.md","text":"https://secwatch.observer/filing/0001493152-21-016427.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1196298/000149315221016427/0001493152-21-016427-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1196298/000149315221016427/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-30T06:32:32.174632+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}